Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor × etoposide phosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma 16 Lymphoma, Non-Hodgkin 11 Lymphoma, Large B-Cell, Diffuse 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Lymphocytic, Chronic, B-Cell 7 Hodgkin Disease 7 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, B-Cell, Marginal Zone 6 Leukemia, Myeloid, Acute 6 Lymphoma, Mantle-Cell 5 Lymphoma, Follicular 5 Small Cell Lung Carcinoma 4 Neuroblastoma 4 Burkitt Lymphoma 4 Testicular Neoplasms 3 Sarcoma 3 Lymphoma, T-Cell 3 Leukemia 3 Central Nervous System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Waldenstrom Macroglobulinemia 2 Testicular Germ Cell Tumor 2 Teratoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Recurrence 2 Osteosarcoma 2 Neoplasms, Germ Cell and Embryonal 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2

Interventions

apatinib 3 vistusertib 2 olaparib 2 camrelizumab 2 atezolizumab 2 Ipilimumab 2 Everolimus 2 trametinib 1 toripalimab 1 tilsotolimod 1 tazemetostat 1 tazarotene 1 spartalizumab 1 seviteronel 1 sargramostim 1 sacituzumab govitecan 1 rucaparib 1 roniciclib 1 romiplostim 1 pyrotinib 1 phosphorylethanolamine 1 pemigatinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 niraparib 1 magrolimab 1 lenvatinib 1 irinotecan sucrosofate 1 famitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡